vimentin
| GO Term | Evidence Code | PMID |
|---|---|---|
| cellular response to lipopolysaccharide | ||
| cellular response to muramyl dipeptide | ||
| cellular response to type II interferon |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110248 | cataract 30 | |
| DOID:12894 | Sjogren's syndrome | |
| DOID:13241 | Behcet's disease | |
| DOID:1936 | atherosclerosis | |
| DOID:7148 | rheumatoid arthritis | |
| DOID:9074 | systemic lupus erythematosus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026